ITM investigator David Beiser, MD, is a co-principal investigator on Strategies to Innovate EmeRgENcy Care Clinical Trials (SIREN), a national network that will collaborate to conduct clinical trials designed to improve the outcomes for patients with neurologic, cardiac, respiratory, hematologic, and trauma-related emergency events.
The University of Illinois at Chicago, the University of Chicago Medicine, and Northwestern Memorial Hospital are part of the SIREN network, which will pool resources and boost patient numbers for emergency medicine clinical trials.
“Establishment of the SIREN Mid-America Clinical and Translational Science Awards Consortium will enable us to find improved treatments for some of our sickest patients including those with heart attacks, lung disease, trauma, and other life-threatening emergencies,” said Beiser in Science Life. “We look forward to working with other SIREN centers, the Consortium, and our community to improve emergency care on the south side of Chicago.”
The SIREN network will carry out clinical trials funded by the the Department of Defense and the ITM’s parent organizations, the National Institutes of Health (NIH) and the National Center for Advancing Translational Sciences (NCATS).
“Our specific SIREN represents a collaboration between SIREN investigators and CTSAs like the ITM at each of the network institutions,” Beiser said. “SIREN will complement CTSA efforts by broadening its involvement in clinical trials to include more trials centered out of the emergency department. SIREN benefits as well as it can leverage the network, contacts, wisdom, and infrastructure of the institutional CTSAs.”
Source: Science Life